<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[José Baselga Research Fund 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=42838></link><description><![CDATA[José Baselga Research Fund 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Tue, 17 Mar 2026 06:13:28 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2023/03/31017998_20230322114128_4594180735.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[José Baselga Research Fund Announces First-Ever Grant to Advance Prion Disease Research]]></title><link>https://www.newswire.co.kr/newsRead.php?no=963686</link><description><![CDATA[BOSTON--(Business Wire/Korea Newswire)--The José Baselga Research Fund (JBRF), supported by Alexion, AstraZeneca Rare Disease, today announced the initiation of the Global José Baselga Research Grant (Baselga Grant), an annual $75,000 grant to advance the treatment of prion diseases, a group of rare progressive neurodegenerative disorders.  JBRF was created by the Baselga family in me...]]></description><pubDate>Wed, 22 Mar 2023 13:35:00 +0900</pubDate></item><item><title><![CDATA[호세바셀가 연구기금, 프리온 질병 연구 발전 위한 최초의 보조금 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=963687</link><description><![CDATA[보스톤--(Business Wire/뉴스와이어)--알렉시온, 아스트라제네카 레어디지즈(Alexion, AstraZeneca Rare Disease)이 후원하는 호세바셀가 연구기금(José Baselga Research Fund, 이하 ‘JBRF’)은 오늘 희귀 진행성 신경퇴행성 장애인 프리온 질병의 치료 연구를 위해 연간 7만5000달러의 보조금을 지원하는 글로벌 호세바셀가 연구 보조금(이하 ‘바셀가 보조금’)의 출범을 발표했다.  JBRF는 암 치료법의 발전에 ...]]></description><pubDate>Wed, 22 Mar 2023 13:35:00 +0900</pubDate></item></channel></rss>